The identification of CNPase expression in the upper airway mucosa, along with its decreased levels in CRSsNP patients, sheds new light on the pathogenesis of respiratory inflammatory diseases and could lead to novel diagnostic and therapeutic approaches. This evidence concerns the gene CNP and chronic rhinosinusitis without nasal polyps.